Study Title

A Prospective Pilot Study to Explore Performance and Efficacy of 68Ga-FAPI PET/CT in Breast Cancer Patients.

Study Details

Description:

Fibroblast activation protein (FAP) is overexpressed in cancer-associated fibroblasts (CAFs), which constitute a major proportion of cells within the tumor microenvironment, especially in breast cancer. 68Ga-FAPI has been developed as a tumor-targeting agent. This prospective study is going to investigate the performance and value of 68Ga- FAPI PET/CT in patients with breast cancer.

© 2021 XCancer Software LLC

Contact XCancer: 402-991-8468